Skof, A.S.; Rotenberg, L.; Hannemann, P.V.F.; Thies, S.; Boschetti-Grützmacher, E.; Kaufmann, A.M.
Human Papillomavirus E7 and p16INK4a mRNA Multiplexed Quantification by a QuantiGeneTM Proof-of-Concept Assay Sensitively Detects Infection and Cervical Dysplasia Severity. Diagnostics 2023, 13, 1135.
https://doi.org/10.3390/diagnostics13061135
AMA Style
Skof AS, Rotenberg L, Hannemann PVF, Thies S, Boschetti-Grützmacher E, Kaufmann AM.
Human Papillomavirus E7 and p16INK4a mRNA Multiplexed Quantification by a QuantiGeneTM Proof-of-Concept Assay Sensitively Detects Infection and Cervical Dysplasia Severity. Diagnostics. 2023; 13(6):1135.
https://doi.org/10.3390/diagnostics13061135
Chicago/Turabian Style
Skof, Anna Sophie, Lina Rotenberg, Paul Viktor Felix Hannemann, Sarah Thies, Eleonora Boschetti-Grützmacher, and Andreas M. Kaufmann.
2023. "Human Papillomavirus E7 and p16INK4a mRNA Multiplexed Quantification by a QuantiGeneTM Proof-of-Concept Assay Sensitively Detects Infection and Cervical Dysplasia Severity" Diagnostics 13, no. 6: 1135.
https://doi.org/10.3390/diagnostics13061135
APA Style
Skof, A. S., Rotenberg, L., Hannemann, P. V. F., Thies, S., Boschetti-Grützmacher, E., & Kaufmann, A. M.
(2023). Human Papillomavirus E7 and p16INK4a mRNA Multiplexed Quantification by a QuantiGeneTM Proof-of-Concept Assay Sensitively Detects Infection and Cervical Dysplasia Severity. Diagnostics, 13(6), 1135.
https://doi.org/10.3390/diagnostics13061135
